Literature DB >> 7658577

The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy.

R A Edelstein1, S B Bauer, M D Kelly, M M Darbey, C A Peters, A Atala, J Mandell, A H Colodny, A B Retik.   

Abstract

PURPOSE: Urinary tract management in children with myelodysplasia is controversial. Some advocate observation alone, while others believe that the prophylactic institution of intermittent catheterization and anticholinergic therapy may help to prevent deterioration.
MATERIALS AND METHODS: A nonrandomized prospective study was instituted to compare the urological outcomes of a cohort of children who were at risk for urological deterioration on the basis of bladder-sphincter dyssynergia and/or high filling or voiding pressures. Those at risk were observed until deterioration occurred, or were placed on prophylactic intermittent catheterization with or without anticholinergic medication.
RESULTS: Of 44 children at risk 35 followed by observation alone had urinary tract deterioration, whereas only 3 of 20 at risk treated with prophylactic intermittent catheterization had deterioration with time.
CONCLUSIONS: Proactive bladder treatment significantly reduced the incidence of upper urinary tract deterioration and need for surgical intervention.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7658577

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  29 in total

1.  Age and factors associated with self-clean intermittent catheterization in patients with spina bifida.

Authors:  T J Atchley; P P Dangle; B D Hopson; A Graham; A A Arynchyna; B G Rocque; D B Joseph; T S Wilson
Journal:  J Pediatr Rehabil Med       Date:  2018

Review 2.  Current approaches to the urologic care of children with spina bifida.

Authors:  David B Joseph
Journal:  Curr Urol Rep       Date:  2008-03       Impact factor: 3.092

3.  Treatment outcomes according to neuropathic bladder sphincter dysfunction type after treatment of oxybutynin chloride in children with myelodysplasia.

Authors:  Minki Baek; Jung Yoon Kang; Jeongyun Jeong; Dae Kyung Kim; Kwang Myung Kim
Journal:  Int Urol Nephrol       Date:  2013-03-31       Impact factor: 2.370

Review 4.  Prevention of chronic kidney disease in spina bifida.

Authors:  Guido Filler; Mireille Gharib; Shelley Casier; Petra Lödige; Jochen H H Ehrich; Sumit Dave
Journal:  Int Urol Nephrol       Date:  2011-01-13       Impact factor: 2.370

5.  Risk factors for renal scarring in children and adolescents with lower urinary tract dysfunction.

Authors:  Cristiane R Leonardo; Maria Francisca T Filgueiras; Mônica M Vasconcelos; Roberta Vasconcelos; Viviane P Marino; Cleidismar Pires; Ana Cristina Pereira; Fernanda Reis; Eduardo A Oliveira; Eleonora M Lima
Journal:  Pediatr Nephrol       Date:  2007-09-14       Impact factor: 3.714

6.  Renal cortical deterioration in children with spinal dysraphism: analysis of risk factors.

Authors:  Sean M DeLair; Jonathan Eandi; Marina J White; Thuan Nguyen; Anthony R Stone; Eric A Kurzrock
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

7.  The predictive factors of hydronephrosis in patients with spina bifida: reports from China.

Authors:  Yan Ma; Bing Li; Longwang Wang; Xiaomin Han
Journal:  Int Urol Nephrol       Date:  2013-03-13       Impact factor: 2.370

Review 8.  [Urological problems in patients with meningomyelocele. Diagnostic studies and management].

Authors:  R Stein; A Schröder; R Beetz; A Ermert; D Filipas; M Fisch; M Goepel; I Körner; B Schönberger; C Sparwasser; M Stöhrer; J W Thüroff
Journal:  Urologe A       Date:  2007-12       Impact factor: 0.639

9.  Pediatric enterocystoplasty: long-term complications and controversies.

Authors:  Eric A Kurzrock
Journal:  World J Urol       Date:  2008-10-10       Impact factor: 4.226

10.  Meningomylocele: An update.

Authors:  R Kapoor; S Agrawal
Journal:  Indian J Urol       Date:  2007-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.